Measurement of Strial Blood Flow in Mouse Cochlea Utilizing an Open Vessel-Window and Intravital Fluorescence Microscopy
September 21st, 2021
2.3K views
An open vessel-window approach using fluorescent tracers provides sufficient resolution for cochlear blood flow (CoBF) measurement. The method facilitates the study of structural and functional changes in CoBF in mouse under normal and pathological conditions.
Overview
This study presents a novel method for measuring cochlear blood flow (CoBF) using an open vessel-window approach with fluorescent tracers. This technique allows for detailed examination of CoBF under both normal and pathological conditions in mice.
Key Study Components
Area of Science
- Neuroscience
- Otolaryngology
- Vascular Biology
Background
- Cochlear blood supply is crucial for maintaining cochlear potential.
- Blood flow dysfunction is linked to various forms of hearing loss.
- Direct measurement of cochlear blood flow is challenging due to anatomical constraints.
- Current techniques for assessing CoBF are still being developed.
Purpose of Study
- To improve understanding of cochlear blood flow dynamics.
- To facilitate better management of hearing disorders related to blood flow issues.
- To demonstrate a new method for measuring CoBF in small animal models.
Methods Used
- Open muscle window technique.
- High-resolution fluorescence microscopy.
- Fluorescent tracers for blood flow measurement.
- Mouse models for experimental validation.
Main Results
- The method provides sufficient resolution for CoBF measurement.
- Facilitates study of structural and functional changes in CoBF.
- Applicable under both normal and pathological conditions.
- Enhances understanding of cochlear blood flow dynamics.
Conclusions
- The open vessel-window approach is effective for CoBF measurement.
- This technique can advance research on hearing disorders.
- Further development of CoBF assessment techniques is warranted.
Frequently Asked Questions
What is cochlear blood flow?
Cochlear blood flow refers to the blood supply to the cochlea, which is essential for its function and health.
Why is measuring cochlear blood flow important?
Understanding cochlear blood flow is crucial for managing hearing disorders linked to blood flow dysfunction.
What challenges exist in measuring cochlear blood flow?
Direct measurement is challenging due to the delicate anatomy of the inner ear.
What method was demonstrated in this study?
The study demonstrated an open muscle window technique combined with high-resolution fluorescence microscopy.
What are the implications of this research?
This research may lead to better understanding and management of hearing disorders related to blood flow issues.
What animal model was used in this study?
Mouse models were used for the experimental validation of the method.
How does this method improve upon previous techniques?
It provides sufficient resolution for detailed examination of cochlear blood flow under various conditions.
Executive Industry Relevance
Assessing cochlear microcirculation is critical for understanding hearing disorders linked to vascular dysfunction, yet direct measurement remains challenging due to anatomical inaccessibility. This method enables in vivo visualization and quantification of cochlear blood flow in mice, supporting mechanistic de-risking in target validation for otologic therapeutics. By providing reproducible hemodynamic readouts, it enhances predictive confidence in preclinical models of hearing loss.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of vascular hypotheses in hearing loss pathology by visualizing structural and functional changes in cochlear microcirculation.
- Operational Value: Supports functional target validation through direct measurement of blood flow velocity and volume in disease-relevant systems.
Screening & Assay Development
- Scientific Value: Generates quantitative blood flow measurements that enable standardized assessment of compound effects on cochlear microcirculation.
- Operational Value: Facilitates assay readiness through reproducible intravital imaging and offline analysis of fluorescently labeled blood cell dynamics.
Translational & Preclinical Research
- Scientific Value: Links cochlear blood flow alterations to hearing function outcomes, supporting translational biomarker identification in noise-exposed and genetic models.
- Operational Value: Provides continuity from discovery through preclinical validation by enabling longitudinal monitoring of vascular responses to pathological insults.
Pipeline & Workflow Integration
The method integrates into discovery workflows by supplying hemodynamic data that informs target selection, assay development, and preclinical efficacy evaluation in hearing loss research.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling direct observation of cochlear blood flow changes under normal and pathological conditions.
- Screening: Delivers quantitative outputs such as flow velocity and volume, allowing teams to compare vascular responses across experimental groups.
- Analytics: Provides measurable parameters including vessel diameter, cell tracking intervals, and volumetric flow calculations for comparative condition analysis.
- Translational Research: Connects microvascular findings to preclinical continuity by modeling noise-induced hearing loss and assessing recovery or intervention effects.
- Enterprise Reuse: Establishes a reusable platform for evaluating vascular contributions to hearing disorders across multiple disease models and therapeutic modalities.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in vascular-mediated hearing loss pathways.
- Operational Value: Enhances standardization and reproducibility through defined surgical preparation, fluorescent labeling, and imaging protocols.
- Strategic Value: Improves go/no-go decisions by enabling early detection of vascular liabilities in lead candidates targeting auditory pathways.
- Portfolio Impact: Informs risk-adjusted prioritization by identifying compounds that modulate cochlear blood flow without adverse vascular effects.
Implementation Considerations
- Requires expertise in microsurgery, anesthesia management, and intravital microscopy techniques.
- Dependent on fluorescence microscopy systems with long working distance objectives and appropriate filter sets for DiO/Dil and FITC-Dextran detection.
- Necessitates cross-team standardization of blood cell labeling, hematocrit adjustment, and intravenous injection procedures.
- Involves adaptation considerations when applying the vessel-window approach to different mouse strains or pathological models.
- Limited by the technical difficulty of surgical access to the cochlear lateral wall and the need for precise vessel visualization.
Biopharma FAQs
Why does tracking DiO-labeled blood cells matter for target validation?
Tracking DiO-labeled blood cells enables measurement of flow velocity, which quantifies cochlear blood flow changes under pathological conditions. This provides functional readouts to validate vascular targets in hearing loss models.
How does isolating the strial artery support discovery pipeline goals?
Isolating the strial artery allows visualization of blood flow in the cochlear lateral wall, a key region for endocochlear potential maintenance. This enables mechanistic de-risking by linking vascular function to hearing outcomes.
What do volumetric flow measurements enable in assay development?
Volumetric flow calculations provide quantitative endpoints to assess compound effects on cochlear microcirculation. These measurements support assay standardization and reproducibility across experimental groups.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures consistent blood flow measurements across animals and experiments, which is essential for reliable data sharing between discovery, preclinical, and translational teams. Standardized protocols reduce variability in vascular phenotyping.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to analyze flow velocity and volume data using statistical tests to compare control and pathological groups. This enables objective assessment of vascular responses to noise exposure or genetic modifications.
Chapters in this video
0:04
Introduction
2:11
Preparation of the Fluorescent-Labeled Blood Cells and Surgery to Create an Open Window
5:39
Imaging of Cochlear Blood Flow Under a Fluorescence Intravital Microscope and Video Analysis
7:54
Results: IVM Imaging of Cochlear Capillaries and Analysis of Change in Vessel Diameter and Blood Flow in the Stria
9:21
Conclusion
